Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin for Diabetic Foot Ulcers
NCT02742233Phase 4Unknown
- Start
- Nov 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in diabetic foot ulcer (DFU). Status: unknown.
02
Drugs
saxagliptin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02742233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02742233.